EFFICACY AND SAFETY OF INTRAVENOUS AND SUBCUTANEOUS TOCILIZUMAB IN A COHORT OF PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS IN REAL-LIFE

被引:2
|
作者
Pomponio, G. [1 ]
Tontini, C. [1 ]
Angeletti, A. [1 ]
Olivari, D. [1 ]
Benfaremo, D. [1 ]
Manfredi, L. [1 ]
Danieli, M. G. [1 ]
Fraticelli, P. [1 ]
Luchetti, M. M. [1 ]
Moroncini, G. [1 ]
Gabrielli, A. [1 ]
机构
[1] Azienda Osped Univ Ospedali Riuniti, Dept Internal Med, Ancona, Italy
关键词
D O I
10.1136/annrheumdis-2017-eular.6724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0400
引用
收藏
页码:1189 / 1189
页数:1
相关论文
共 50 条
  • [31] EFFICACY, SAFETY AND PHARMACOKINETICS OF SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH OR WITHOUT AN INTRAVENOUS LOADING DOSE
    Nash, P.
    Ludivico, C.
    Delaet, I.
    Qi, K.
    Murthy, B.
    Corbo, M.
    Kaine, J.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 12 - 12
  • [32] EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS OVERLAP SYNDROME
    Wakabayashi, H.
    Kino, S.
    Hasegawa, M.
    Sudo, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1518 - 1519
  • [33] Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis
    Ahn, Soo Min
    Oh, Ji Seon
    Heo, Hyun Mi
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1728 - 1730
  • [34] REAL-LIFE EFFICACY AND SAFETY OF IXEKIZUMAB IN A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS: A SINGLE-CENTER RETROSPECTIVE STUDY
    Bellis, E.
    Donzella, D.
    Crepaldi, G.
    Data, V.
    Gammino, M.
    Guardo, V.
    Lomater, C.
    Marucco, E.
    Saracco, M.
    Iagnocco, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1790 - 1790
  • [35] ADVERSE EVENTS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS IN A REAL-LIFE SETTING
    Santos-Moreno, Pedro
    Villarreal, Laura
    Saavedra-Martinez, Ginna
    Becerra, Camilo
    Garcia, Manuel
    Zea, Katerine
    Aza, Anggie
    Palacio, Natalia
    Boon, Mili
    Cardozo, Ana
    Corredor, Sandra
    Giraldo, Vanessa
    Martinez, Gustavo
    Martinez, Paola
    Sanchez, Adriana
    Ballesteros, Giovanni
    Castillo, Edwin
    Giraldo, Rodrigo
    Gomez, Danny
    Bello-Gualtero, Juan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 129 - 129
  • [36] Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    McLaughlin, Maeve
    Oestoer's, Andrew
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 429 - 437
  • [37] EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS: A MONOCENTRIC REAL-LIFE EXPERIENCE
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Sartorelli, Silvia
    Cariddi, Adriana
    Baldissera, Elena
    Dagna, Lorenzo
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1770 - 1771
  • [38] EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS: A MONOCENTRIC REAL-LIFE EXPERIENCE
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Sartorelli, Silvia
    Baldissera, Elena
    Dagna, Lorenzo
    RHEUMATOLOGY, 2019, 58
  • [39] Efficacy and Safety of Tocilizumab in Giant Cell Arteritis: A Monocentric Real-life Experience
    Baldissera, Elena
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Sartorelli, Silvia
    Dagna, Lorenzo
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2019, 58